UT Health San Antonio urologist discovers combined anti-seizure drug and omega-3 may lower COVID-19 risks

September 9, 2024

  Ronald Rodriguez, MD, PhD, professor of medical education and urology at Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) discovers the combination of valproic acid and docosahexaenoic acid (DHA) may reduce the risk of contracting COVID-19 and lessen its severity, according to […]



Healing young minds: UT Health San Antonio’s initiatives to address the adolescent mental health crisis

September 6, 2024

This story is featured in the September 2024 issue of the Bexar County Medical Society’s San Antonio Medicine Magazine. For the past decade, adolescent mental health disorders have skyrocketed, an issue propelled even further by the COVID-19 pandemic. Mental health has declined surreptitiously for millions of people in recent years, affecting even the youngest among […]



Clinical trial to investigate causes of diabetes, obesity in individuals with spinal cord injury and potential mitigatory effects of semaglutide

September 4, 2024

A first-of-its-kind investigation into the mechanisms behind diabetes and obesity in people with spinal cord injury and the antidiabetic and anti-obesity effects of semaglutide was recently approved for $3 million in National Institutes of Health funding. “This is one population in which they are susceptible to be more obese and having worse diabetes risk and […]

Personal challenge to global solution

September 4, 2024

UT Health San Antonio urologist demonstrates potential of valproic acid-DHA in lessening risk of contracting COVID-19   When the world locked down due to the COVID-19 pandemic in 2020, rather than slowing down, this distinguished urologist and medical educator merely switched gears.   Ronald Rodriguez, MD, PhD, is a professor of medical education and urology at Joe […]